Lyda Hill Philanthropies reposted this
It typically takes more than 10 years and $1 billion to develop a new cancer drug, resulting in expensive medication. Using AI technology, Reboot Rx, a DRK Foundation portfolio organization, is fast-tracking this process and turning generic drugs into affordable, timely, and life-saving treatments for patients. A new case study by Amazon Web Services (AWS) and The Chronicle of Philanthropy details Reboot Rx’s breakthrough innovation and how they use technology to scale their impact.
We are proud to share this case study by Amazon Web Services (AWS) and The Chronicle of Philanthropy featuring our work at Reboot Rx and an interview with CEO Laura Kleiman, PhD about our founding story. The case study describes how our AI technology helps us rapidly identify the most promising generic drugs to repurpose for treating cancer and how we drive widespread adoption in the standard of care for patients. It also highlights the importance of our nonprofit model, which allows us to form strategic partnerships, leverage philanthropic dollars, and focus on the drugs that maximize benefits for patients without commercial considerations. Check it out! #RebootRx #TheSolutionMayAlreadyExist #cancer #drugrepurposing #research #patientimpact #nonprofit #startups #AI #technology
